The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.

The sensitivity and specificity profile of measuring levels of prostate-specific antigen (PSA) to select men for prostate biopsy is not optimal. This has prompted the construction of nomograms and artificial neural networks (ANNs) to increase the performance of PSA measurements.